Luca Filippi

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 106

Top Venues

Expert review of medical devices

Diagnostics (Basel, Switzerland)

Expert review of anticancer therapy

Life (Basel, Switzerland)

Ospedale Santa Maria Goretti

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ospedale Santa Maria Goretti Nov 01 2010 - May 03 2018

Italy

Tenured Nuclear Medicine Specialist - highly specialized responsibility in PET imaging and radionuclide therapy planning :: Department of Nuclear Medicine

Azienda Sanitaria Universitaria Integrata di Trieste Nov 01 2007 - Oct 31 2010

Italy

Tenured Nuclear Medicine Specialist :: Radiology, Nuclear Medicine Unit

Fondazione PTV Policlinico Tor Vergata Jan 01 2006 - Oct 30 2007

Italy

cunsultant :: Biopathology and Diagnostic Imaging

Publications

Luca Filippi, Martin W Brechbiel
Molecular Breast Imaging of HER2-Positive Breast Cancer in the Era of PHERGain Trial: The past, the Present, and the Prospects. Cancer biotherapy & radiopharmaceuticals (2024)
Proietti Ilaria, Luca Filippi, Oreste Bagni, Concetta Potenza
Metabolic Imaging of Advanced Basal Cell Carcinoma Treated with Sonidegib: A Retrospective Case Series Study. Journal of clinical medicine 13 (17) (2024)
Riccardo Camedda, Viviana Frantellizzi, Roberta Danieli, Giuseppe De Vincentis, Luca Filippi
Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review. Expert review of anticancer therapy 24 (3-4) (2024)
Luca Urso, Luca Filippi
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? Expert review of medical devices (2024)
Luca Filippi, Luca Urso, Laura Evangelista
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview. Current issues in molecular biology 46 (4) (2024)
Luca Filippi, Luca Urso, Laura Evangelista
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview. Current issues in molecular biology 46 (4) (2024)
Riccardo Camedda, Viviana Frantellizzi, Roberta Danieli, Giuseppe De Vincentis, Luca Filippi
Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review. Expert review of anticancer therapy (2024)
Matteo Bauckneht, Luca Filippi
Pentixather: paving the way for radioligand therapy in oncohematology. Expert review of anticancer therapy 24 (5) (2024)
Matteo Bauckneht, Luca Filippi
Pentixather: paving the way for radioligand therapy in Oncohematology. Expert review of anticancer therapy (2024)
Luca Filippi, Martin W Brechbiel
Molecular Breast Imaging of HER2-Positive Breast Cancer in the Era of PHERGain Trial: The past, the Present, and the Prospects. Cancer biotherapy & radiopharmaceuticals 39 (6) (2024)
Valerio Da Ros, Luca Filippi, Francesco Garaci
Intra-arterial administration of PSMA-targeted radiopharmaceuticals for brain tumors: is the era of interventional theranostics next? Expert review of anticancer therapy (2024)
Matteo Bauckneht, Luca Filippi
Pentixather: paving the way for radioligand therapy in oncohematology. Expert review of anticancer therapy (2024)
Luca Filippi, Luca Urso, Laura Evangelista
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview. Current issues in molecular biology 46 (4) (2024)
Luca Urso, Luca Filippi
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? Expert review of medical devices (2024)
Luca Filippi, Annamaria Lacanfora, Francesco Garaci
One Fell Swoop: Septic Muscle Embolism and Central Venous Catheter Infection Imaged with [ 18 F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Diagnostics (Basel, Switzerland) 14 (2) (2024)
Riccardo Camedda, Viviana Frantellizzi, Roberta Danieli, Giuseppe De Vincentis, Luca Filippi
Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review. Expert review of anticancer therapy (2024)
Luca Filippi
Re: "Evaluating the Diagnostic Efficacy of 99m Tc-Methionine Single-Photon Emission Computed Tomography-Computed Tomography: A Head-to-Head Comparison with 11 C-Methionine Positron Emission Tomography-Magnetic Resonance Imaging in Glioma Patients" by Kumar et al. Cancer biotherapy & radiopharmaceuticals 39 (5) (2024)
Luca Filippi
Re: "Evaluating the Diagnostic Efficacy of 99m Tc-Methionine Single-Photon Emission Computed Tomography-Computed Tomography: A Head-to-Head Comparison with 11 C-Methionine Positron Emission Tomography-Magnetic Resonance Imaging in Glioma Patients" by Kumar et al. Cancer biotherapy & radiopharmaceuticals (2024)
Luca Filippi, Annamaria Lacanfora, Francesco Garaci
One Fell Swoop: Septic Muscle Embolism and Central Venous Catheter Infection Imaged with [ 18 F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Diagnostics (Basel, Switzerland) 14 (2) (2024)
Luca Filippi
COVID-19 lessons learned: medical devices at the core of global healthcare. A foreword on new challenges for expert review of medical devices! Expert review of medical devices 20 (1) (2023)
Miriam Conte, Maria Silvia De Feo, Marko Magdi Abdou Sidrak, Ferdinando Corica, Joana Gorica, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review. Pharmaceutics 15 (3) (2023)
Luca Filippi
COVID-19 lessons learned: medical devices at the core of global healthcare. A foreword on new challenges for expert review of medical devices! Expert review of medical devices (2023)
Laura Evangelista, Francesco Fiz, Riccardo Laudicella, Francesco Bianconi, Angelo Castello, Priscilla Guglielmo, Virginia Liberini, Luigi Manco, Viviana Frantellizzi, Alessia Giordano, Luca Urso, Stefano Panareo, Barbara Palumbo, Luca Filippi
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature. Cancers 15 (12) (2023)
Luca Filippi, Luca Urso, Francesco Bianconi, Barbara Palumbo, Maria Cristina Marzola, Laura Evangelista, Orazio Schillaci
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: towards a personalised approach. Expert review of molecular diagnostics (2023)
Luca Filippi, Viviana Frantellizzi, Paola Bartoletti, Giuseppe De Vincentis, Orazio Schillaci, Laura Evangelista
Head-to-Head Comparison between FDG and 11 C-Methionine in Multiple Myeloma: A Systematic Review. Diagnostics (Basel, Switzerland) 13 (12) (2023)
Maria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, Alessio Farcomeni, Luca Filippi, Elisa Lodi Rizzini, Valentina Lavelli, Maria Lina Stazza, Tania Di Raimondo, Giuseppe Fornarini, Sara Elena Rebuzzi, Mammini Filippo, Paolo Mammucci, Andrea Marongiu, Fabio Monari, Giuseppe Rubini, Angela Spanu, Giuseppe De Vincentis
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study. Biomedicines 11 (4) (2023)
Luca Filippi, Orazio Schillaci
NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime? Expert review of anticancer therapy (2023)
Ferdinando Corica, Maria Silvia De Feo, Joana Gorica, Marko Magdi Abdou Sidrak, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside. Diagnostics (Basel, Switzerland) 13 (6) (2023)
Luca Filippi, Ilaria Proietti, Vincenzo Petrozza, Sara Aversa, Francesco Fiorentino, Concetta Potenza, Oreste Bagni, Orazio Schillaci, Maria Cantonetti
[ 18 F]FDG PET/CT in a Case of Mycosis Fungoides Showing an Unusual Adverse Reaction to Mogamulizumab: Correlation Between Imaging and Histological Findings. Cancer biotherapy & radiopharmaceuticals (2023)
Luca Filippi
COVID-19 lessons learned: medical devices at the core of global healthcare. A foreword on new challenges for Expert Review of Medical Devices! Expert review of medical devices (2023)
Ilaria Proietti, Luca Filippi, Ersilia Tolino, Nicoletta Bernardini, Francesca Svara, Federica Trovato, Claudio Di Cristofano, Vincenzo Petrozza, Oreste Bagni, Andrea Vizzaccaro, Nevena Skroza, Concetta Potenza
Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature. Biomedicines 11 (11) (2023)
Luca Urso, Luca Filippi, Angelo Castello, Maria Cristina Marzola, Mirco Bartolomei, Corrado Cittanti, Luigia Florimonte, Massimo Castellani, Paolo Andrea Zucali, Alessio Bruni, Roberto Sabbatini, Massimo Dominici, Stefano Panareo, Laura Evangelista
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? Journal of clinical medicine 12 (22) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Laura Evangelista, Giuseppe De Vincentis, Viviana Frantellizzi
Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review. Life (Basel, Switzerland) 13 (4) (2023)
Miriam Conte, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Marko Magdi Abdou Sidrak, Flaminia De Cristofaro, Luca Filippi, Maria Ricci, Giuseppe De Vincentis, Viviana Frantellizzi
A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression. Biomolecules 13 (4) (2023)
Miriam Conte, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Marko Magdi Abdou Sidrak, Flaminia De Cristofaro, Luca Filippi, Maria Ricci, Giuseppe De Vincentis, Viviana Frantellizzi
A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression. Biomolecules 13 (4) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Laura Evangelista, Giuseppe De Vincentis, Viviana Frantellizzi
Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review. Life (Basel, Switzerland) 13 (4) (2023)
Marco D'Arienzo, Emilio Mezzenga, Amedeo Capotosti, Oreste Bagni, Luca Filippi, Marco Capogni, Luca Indovina, Anna Sarnelli
The Importance of Uncertainty Analysis and Traceable Measurements in Routine Quantitative 90 Y-PET Molecular Radiotherapy: A Multicenter Experience. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Luca Filippi, Luca Urso, Francesco Bianconi, Barbara Palumbo, Maria Cristina Marzola, Laura Evangelista, Orazio Schillaci
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach. Expert review of molecular diagnostics (2023)
Joana Gorica, Maria Silvia De Feo, Ferdinando Corica, Marko Magdi Abdou Sidrak, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review. International journal of molecular sciences 24 (4) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Joana Gorica, Ferdinando Corica, Miriam Conte, Luca Filippi, Giuseppe De Vincentis, Viviana Frantellizzi
Medication and ECG Patterns That May Hinder SPECT Myocardial Perfusion Scans. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Luca Filippi, Laura Evangelista, Orazio Schillaci
Integrated use of 90 Y-labeled microspheres and immune checkpoint inhibitors in hepatic tumors: current status and future directions. Expert review of gastroenterology & hepatology (2023)
Laura Evangelista, Francesco Fiz, Riccardo Laudicella, Francesco Bianconi, Angelo Castello, Priscilla Guglielmo, Virginia Liberini, Luigi Manco, Viviana Frantellizzi, Alessia Giordano, Luca Urso, Stefano Panareo, Barbara Palumbo, Luca Filippi
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature. Cancers 15 (12) (2023)
Luca Filippi
COVID-19 lessons learned: medical devices at the core of global healthcare. A foreword on new challenges for expert review of medical devices! Expert review of medical devices 20 (1) (2023)
Luca Filippi, Viviana Frantellizzi, Giuseppe De Vincentis, Orazio Schillaci, Laura Evangelista
Clinical Applications of TSPO PET for Glioma Imaging: Current Evidence and Future Perspective-A Systematic Review. Diagnostics (Basel, Switzerland) 13 (10) (2023)
Luca Filippi, Ilaria Proietti, Vincenzo Petrozza, Concetta Potenza, Oreste Bagni, Orazio Schillaci
The Prognostic Role of [ 18 F]FDG PET/CT in Patients with Advanced Cutaneous Squamous Cell Carcinoma Submitted to Cemiplimab Immunotherapy: A Single-Center Retrospective Study. Cancer biotherapy & radiopharmaceuticals (2023)
Luca Filippi
COVID-19 lessons learned: medical devices at the core of global healthcare. A foreword on new challenges for expert review of medical devices! Expert review of medical devices 20 (1) (2023)
Miriam Conte, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Marko Magdi Abdou Sidrak, Flaminia De Cristofaro, Luca Filippi, Maria Ricci, Giuseppe De Vincentis, Viviana Frantellizzi
A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression. Biomolecules 13 (4) (2023)
Luca Filippi, Luca Urso, Orazio Schillaci, Laura Evangelista
[ 18 F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review. Diagnostics (Basel, Switzerland) 13 (15) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Laura Evangelista, Giuseppe De Vincentis, Viviana Frantellizzi
Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review. Life (Basel, Switzerland) 13 (4) (2023)
Luca Filippi, Luca Urso, Viviana Frantellizzi, Katia Marzo, Maria Cristina Marzola, Orazio Schillaci, Laura Evangelista
Molecular imaging of PARP in cancer: state-of-the-art. Expert review of molecular diagnostics (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Laura Evangelista, Giuseppe De Vincentis, Viviana Frantellizzi
Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review. Life (Basel, Switzerland) 13 (4) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review. International journal of molecular sciences 24 (4) (2023)
Laura Evangelista, Viviana Frantellizzi, Orazio Schillaci, Luca Filippi
Radiolabeled FAPI in pancreatic cancer: can it be an additional value in the management of patients? Expert review of anticancer therapy (2023)
Luca Filippi, Laura Evangelista, Orazio Schillaci
Integrated use of 90 Y-labeled microspheres and immune checkpoint inhibitors in hepatic tumors: current status and future directions. Expert review of gastroenterology & hepatology (2023)
Nozipho Nyakale, Luca Filippi, Colleen Aldous, Machaba Michael Sathekge
Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma. Cancers 15 (7) (2023)
Miriam Conte, Maria Silvia De Feo, Marko Magdi Abdou Sidrak, Ferdinando Corica, Joana Gorica, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review. Pharmaceutics 15 (3) (2023)
Luca Filippi, Nicoletta Urbano, Orazio Schillaci
Total-body PET/CT: how will it change theranostics in oncology? Expert review of medical devices (2023)
Maria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, Alessio Farcomeni, Luca Filippi, Elisa Lodi Rizzini, Valentina Lavelli, Maria Lina Stazza, Tania Di Raimondo, Giuseppe Fornarini, Sara Elena Rebuzzi, Mammini Filippo, Paolo Mammucci, Andrea Marongiu, Fabio Monari, Giuseppe Rubini, Angela Spanu, Giuseppe De Vincentis
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study. Biomedicines 11 (4) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Joana Gorica, Ferdinando Corica, Miriam Conte, Luca Filippi, Giuseppe De Vincentis, Viviana Frantellizzi
Medication and ECG Patterns That May Hinder SPECT Myocardial Perfusion Scans. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Miriam Conte, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Marko Magdi Abdou Sidrak, Flaminia De Cristofaro, Luca Filippi, Maria Ricci, Giuseppe De Vincentis, Viviana Frantellizzi
A Systematic Review on Dementia and Translocator Protein (TSPO): When Nuclear Medicine Highlights an Underlying Expression. Biomolecules 13 (4) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review. International journal of molecular sciences 24 (4) (2023)
Luca Filippi, Viviana Frantellizzi, Paola Bartoletti, Giuseppe De Vincentis, Orazio Schillaci, Laura Evangelista
Head-to-Head Comparison between FDG and 11 C-Methionine in Multiple Myeloma: A Systematic Review. Diagnostics (Basel, Switzerland) 13 (12) (2023)
Luigi Castorina, Alessio Danilo Comis, Angela Prestifilippo, Natale Quartuccio, Stefano Panareo, Luca Filippi, Serena Castorina, Dario Giuffrida
Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response. Journal of clinical medicine 13 (1) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review. International journal of molecular sciences 24 (4) (2023)
Luigi Castorina, Alessio Danilo Comis, Angela Prestifilippo, Natale Quartuccio, Stefano Panareo, Luca Filippi, Serena Castorina, Dario Giuffrida
Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response. Journal of clinical medicine 13 (1) (2023)
Luca Filippi, Agostino Chiaravalloti
Prostate Cancer: From Molecular Imaging to Immunological and Target Therapies. Biomedicines 11 (4) (2023)
Egesta Lopci, Angelo Castello, Luca Filippi
Novelties from the Joint EANM/SNMMI/ANZSNM Guidelines on Immunotherapy. Cancer biotherapy & radiopharmaceuticals (2023)
Miriam Conte, Maria Silvia De Feo, Viviana Frantellizzi, Miriam Tomaciello, Francesco Marampon, Laura Evangelista, Luca Filippi, Giuseppe De Vincentis
Radio-Guided Lung Surgery: A Feasible Approach for a Cancer Precision Medicine. Diagnostics (Basel, Switzerland) 13 (16) (2023)
Marko Magdi Abdou Sidrak, Maria Silvia De Feo, Ferdinando Corica, Joana Gorica, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review. International journal of molecular sciences 24 (4) (2023)
Miriam Conte, Maria Silvia De Feo, Marko Magdi Abdou Sidrak, Ferdinando Corica, Joana Gorica, Giorgia Maria Granese, Luca Filippi, Giuseppe De Vincentis, Viviana Frantellizzi
Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook. Diagnostics (Basel, Switzerland) 13 (10) (2023)
Francesco Bianconi, Roberto Salis, Mario Luca Fravolini, Muhammad Usama Khan, Matteo Minestrini, Luca Filippi, Andrea Marongiu, Susanna Nuvoli, Angela Spanu, Barbara Palumbo
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [ 18 F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer. Sensors (Basel, Switzerland) 23 (18) (2023)
Laura Evangelista, Viviana Frantellizzi, Orazio Schillaci, Luca Filippi
Radiolabeled FAPI in pancreatic cancer: can it be an additional value in the management of patients? Expert review of anticancer therapy (2023)
Luca Filippi, Agostino Chiaravalloti
Prostate Cancer: From Molecular Imaging to Immunological and Target Therapies. Biomedicines 11 (4) (2023)
Ferdinando Corica, Maria Silvia De Feo, Joana Gorica, Marko Magdi Abdou Sidrak, Miriam Conte, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
PET Imaging of Neuro-Inflammation with Tracers Targeting the Translocator Protein (TSPO), a Systematic Review: From Bench to Bedside. Diagnostics (Basel, Switzerland) 13 (6) (2023)
Miriam Conte, Maria Silvia De Feo, Marko Magdi Abdou Sidrak, Ferdinando Corica, Joana Gorica, Luca Filippi, Orazio Schillaci, Giuseppe De Vincentis, Viviana Frantellizzi
Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review. Pharmaceutics 15 (3) (2023)
Giulia Poletto, Diego Cecchin, Stefania Sperti, Luca Filippi, Nicola Realdon, Laura Evangelista
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review. Current issues in molecular biology 44 (11) (2022)
Luca Filippi, Barbara Palumbo, Oreste Bagni, Viviana Frantellizzi, Giuseppe De Vincentis, Orazio Schillaci
DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review. Life (Basel, Switzerland) 13 (1) (2022)
Luca Filippi, Oreste Bagni, Orazio Schillaci
Digital PET/CT with 18 F-FACBC in early castration-resistant prostate cancer: our preliminary results. Expert review of medical devices 19 (7) (2022)
Luca Filippi, Ilaria Proietti, Vincenzo Petrozza, Oreste Bagni, Orazio Schillaci
Cutaneous Squamous Cell Carcinoma Subjected to Anti PD-1 Immunotherapy: Monitoring Response Through Serial PET/CT Scans with 18 F-FDG. Cancer biotherapy & radiopharmaceuticals 37 (3) (2022)
Luca Filippi, Orazio Schillaci, Barbara Palumbo
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward. Expert review of molecular diagnostics 22 (2) (2022)
Luca Filippi, Arthur J Braat, Orazio Schillaci
The era of prostate-specific membrane antigen (PSMA)-based theranostics for hepatocellular carcinoma is upcoming: are we ready for it? European journal of nuclear medicine and molecular imaging 49 (12) (2022)
Luca Filippi, Antonia Dimitrakopoulou-Strauss, Laura Evangelista, Orazio Schillaci
Long axial field-of-view PET/CT devices: are we ready for the technological revolution? Expert review of medical devices 19 (10) (2022)
Luca Filippi, Barbara Palumbo, Oreste Bagni, Viviana Frantellizzi, Giuseppe De Vincentis, Orazio Schillaci
DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review. Life (Basel, Switzerland) 13 (1) (2022)
Luca Filippi, Barbara Palumbo, Oreste Bagni, Viviana Frantellizzi, Giuseppe De Vincentis, Orazio Schillaci
DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review. Life (Basel, Switzerland) 13 (1) (2022)
Luca Filippi, Oreste Bagni, Ermanno Notarianni, Adelchi Saltarelli, Cesare Ambrogi, Orazio Schillaci
PET/CT with 18 F-choline or 18 F-FDG in Hepatocellular Carcinoma Submitted to 90 Y-TARE: A Real-World Study. Biomedicines 10 (11) (2022)
Luca Filippi, Barbara Palumbo, Viviana Frantellizzi, Susanna Nuvoli, Giuseppe De Vincentis, Angela Spanu, Orazio Schillaci
Prostate-specific membrane antigen-directed imaging and radioguided surgery with single-photon emission computed tomography: state of the art and future outlook. Expert review of medical devices (2022)
Luca Filippi, Isabella Palumbo, Oreste Bagni, Orazio Schillaci, Cynthia Aristei, Barbara Palumbo
Somatostatin Receptor Targeted PET-Imaging for Diagnosis, Radiotherapy Planning and Theranostics of Meningiomas: A Systematic Review of the Literature. Diagnostics (Basel, Switzerland) 12 (7) (2022)
Joana Gorica, Maria Silvia De Feo, Luca Filippi, Viviana Frantellizzi, Orazio Schillaci, Giuseppe De Vincentis
Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives. Expert review of molecular diagnostics (2022)
Luca Filippi, Francesco Bianconi, Orazio Schillaci, Angela Spanu, Barbara Palumbo
The Role and Potential of 18 F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Luca Filippi, Oreste Bagni, Carmelo Crisafulli, Ivan Cerio, Gabriele Brunotti, Agostino Chiaravalloti, Orazio Schillaci, Franca Dore
Detection Rate and Clinical Impact of PET/CT with 18 F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study. Biomedicines 10 (1) (2022)
Luca Filippi, Barbara Palumbo, Oreste Bagni, Viviana Frantellizzi, Giuseppe De Vincentis, Orazio Schillaci
DNA Damage Repair Defects and Targeted Radionuclide Therapies for Prostate Cancer: Does Mutation Really Matter? A Systematic Review. Life (Basel, Switzerland) 13 (1) (2022)
Luca Filippi, Angela Spanu, Oreste Bagni, Orazio Schillaci, Barbara Palumbo
Imaging Findings of 18 F-Choline and 18 F-DOPA PET/MRI in a Case of Glioblastoma Multiforme Pseudoprogression: Correlation with Clinical Outcome. Nuclear medicine and molecular imaging 56 (5) (2022)
Luca Filippi, Viviana Frantellizzi, Fabio Monari, Elisa Lodi Rizzini, Elena Tabacchi, Riccardo Pirisino, Andrea Marongiu, Susanna Nuvoli, Oreste Bagni, Giuseppe De Vincentis, Orazio Schillaci, Angela Spanu
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study. Diagnostics (Basel, Switzerland) 11 (7) (2021)
Luca Filippi, Viviana Frantellizzi, Agostino Chiaravalloti, Mariano Pontico, Maria Silvia De Feo, Ferdinando Corica, Melissa Montebello, Orazio Schillaci, Giuseppe De Vincentis, Oreste Bagni
Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer. International journal of molecular sciences 22 (6) (2021)
Luca Filippi, Orazio Schillaci
Digital PET and detection of recurrent prostate cancer: what have we gained, and what is still missing? Expert review of medical devices 18 (11) (2021)
Agostino Chiaravalloti, Maria Ricci, Andrea Cimini, Francesca Russo, Francesco Ursini, Luca Filippi, Orazio Schillaci
18F-FDOPA PET/CT SUV-Derived Indices and Volumetric Parameters Correlation in Patients with Primary Brain Tumors. Cancers 13 (17) (2021)
Proietti Ilaria, Nevena Skroza, Luca Filippi, Nicoletta Bernardini, Alessandra Mambrin, Ersilia Tolino, Giovanni Rossi, Anna Marchesiello, Federica Marraffa, Salvatore Volpe, Oreste Bagni, Concetta Potenza
Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy. Life (Basel, Switzerland) 11 (7) (2021)
Luca Filippi, Ilaria Proietti, Orazio Schillaci, Concetta Potenza, Oreste Bagni
A fare case of pancreatic metastasis from malignant melanoma mimicking pancreatitis on 18F-FDG PET/CT. Journal of the Egyptian National Cancer Institute 33 (1) (2021)
Luca Filippi, Agostino Chiaravalloti, Orazio Schillaci, Oreste Bagni
The potential of PSMA-targeted alpha therapy in the management of prostate cancer. Expert review of anticancer therapy 20 (10) (2020)

Luca Filippi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Luca Filippi